AbbVie accepting scholarship applications for 2023-2024
AbbVie will award 40 scholarships to defray expenses of students with CF
As it has done for decades, AbbVie is seeking applications from U.S. cystic fibrosis (CF) patients for its latest round of college scholarships.
Eligible undergraduate and graduate students may apply online or by mail through 11 a.m. ET May 24 for an AbbVie Cystic Fibrosis Scholarship for the 2023-2024 academic school year.
AbbVie again will award 40 scholarships of $3,000 to help defray students’ expenses. Winners will notified by July 21 and an announcement will be made Sept. 13.
Scholarship recipients also will be able to compete for an extra $22,000 through either the Thriving Undergraduate Student or Thriving Graduate Student classification. These awards are based on essay submissions, creative presentations, achievements, grades, and public votes. Applicants will notified of results by Oct. 6, and recipients will be announced Nov. 2.
Public voting will comprise 30% of an applicant’s overall score and will take place Sept. 13-27. A panel of AbbVie-selected judges will award the point balance.
“AbbVie has a long history of being committed to more than medicine within the CF community,” John Duffey, AbbVie vice president, U.S. Specialty, said in a press release. “Each year, we call upon students to share their experiences and achievements while pursuing higher education so that they can be recognized and awarded for their resilience and hard work,” he said.
If they are continuing with higher education, past recipients of awards other than Thriving Student are welcome to apply for this scholarship round. Applicants must be diagnosed with CF, enrolled in or awaiting acceptance from an accredited school during the 2023-2024 school year, and U.S. citizens or legal and permanent U.S. residents.
“It was a huge honor to receive the title of the 2022 AbbVie Thriving Graduate Student, and I am forever grateful,” Ashley S. said in AbbVie’s press release. “It was my validation that I would be able to be financially stable throughout my master’s program and that I do have what it takes to complete the program and change people’s lives as an occupational therapist.”
Since the program’s 1993 inception, more than $3.8 million in scholarships have been awarded. The goal is to ease the financial burdens associated with cystic fibrosis, and to support young patients in their collegiate pursuits.
Scholarship applicants are not required to have used, be using, or plan to use any AbbVie-marketed therapeutic or product.
Nearly 40,000 U.S. residents have CF, according to AbbVie, more than half of them 18 or older. The company said its scholarship program is part of an “ongoing commitment to the CF community.”
Those with questions about the program should send them in an email to [email protected].
About the Author
